Search CommunityWalk:
Create_a_map_small
Mymaps_small



Blank

Integrated BioTherapeutics Inc

Address:
21 Firstfield Road
--
Gaithersburg, MD, USA
1-240-454-8934

Category: Biotechnology/Biopharmaceutical - Vaccines

Used in the following map:

Maryland Biotech Industry Map

Integrated BioTherapeutics Inc (IBT) is a research-based biotechnology company engaged in the development of vaccines and discovery of small molecules targeting emerging infectious agents. Its focus is on the development of vaccines and immunotherapeutics for complications resulting from Staphylococcal and Streptococcal infections.

Integrated BioTherapeutics uses its proprietary technology to develop a multivalent panfilovirus vaccine for prevention of the deadly hemorrhagic fevers caused by different strains of Ebola and Marburg viruses. Its technology is based on virus-like particles, hollow particles that mimic the ebola- or marburgvirus, but are devoid of the viral genetic information. The company's technology VLP system is not vector-based and does not require another viral system for propagation and efficiency.

Integrated BioTherapeutics develops vaccines and therapeutics for two groups of infectious diseases: infections and septic shock caused by staphylococcal and streptococcal infections and viral hemorrhagic fevers. Its vaccines rely on a structure-based design and are designed to induce antibodies for neutralization of superantigens. The company is also developing a set of recombinant vaccines for streptococcal pyrogenic exotoxins.

Integrated BioTherapeutics targets various toxins produced by bacteria that aid them to evade the immune response and establish persistent or acute infections using a portfolio of proprietary recombinant mutant vaccines and vaccine candidates. The company's product pipeline includes: FiloVax, STEBVax, Multivalent Staph Vaccine, SEB-HIG and TSS-HIG. Its services include antiviral testing, antibiotic testing, custom testing etc.

Integrated BioTherapeutics has alliances with National Institute of Health, NCI-Frederick, Omrix biopharmaceuticals, BD (Becton, Dickinson and Company), Functional Genetics, Inc and so on.